Status:
WITHDRAWN
Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Chronic Hepatitis B
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Combination therapies using nucleos(t)ide analogues lead to higher viral suppression although it may not be sustained for long. Also it remains unknown if combination of more potent analogues is more ...
Eligibility Criteria
Inclusion
- HBeAg negative at screening
- Documented chronic Hepatitis B
- Treatment naive
- Compensated liver disease
Exclusion
- Chronic Hepatitis B with Child Pugh B \& C
- HBeAg positive
- Decompensated liver disease
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01260610
Start Date
June 1 2011
End Date
June 1 2011
Last Update
June 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver & Biliary Sciences
New Delhi, India